Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty

August 2009

You'll soon see Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty.

Think of it as a more powerful cousin to clopidogrel (Plavix).

Effient is more effective than clopidogrel for preventing heart attacks after angioplasty...but it also causes more bleeding.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote